Home
About Us
Information & Guidelines
Article Processing Charges
Open Access Policy
Terms and Conditions
Privacy Policy
Information For Authors
Information Editorial Board
Contact Us
FAQ
Paper Submission Guideline
Register
Login
Submit Now
Vol - 28, Issue - 02
Full-Text PDF
About the Journal
Download
[This article belongs to Volume - 28, Issue - 02]
International Medical Journal
Journal ID
:
IMJ-01-02-2021-745
Total View
:
348
Title
:
The role of Galactin-3 in Schizophrenia Disease and the relationship of Oxidative Stress and Inflammation
Abstract
: The present study was to evaluate the role of Galactin-3 in Schizophrenia Disease and the relationship of Oxidative Stress and Inflammation. A total A total of 66 patients, 33 Schizophrenia and 33 normal, who were not diagnosed with acute or chronic infection that have been shown to affect galectin-3 levels, were included in the study. Categorical fluency tests have been carried out using different scales and ELISA method was used to measure galectin-3 level. The findings of the study showed that Galectin-3 level of the Schizophrenia’s group was found higher than the control group (Schizophrenia 7.52 [2.22-16.19], control 7.02 [1.87-20]. However, it was not statistically significant (p = 0.211). According to the results, galectin-3 levels of Schizophrenia’s patients according to SAPS score; the galectin-3 levels of patients in the moderate-severe Schizophrenia (stage 6) group were found to be statistically significantly higher (moderate-severe stage 10.34 [4.83-11.99], mild-moderate stage 8.54 [2.82-15.63], control 6.71 [2.67-32]; p= 0.012). These findings support the existence of galectin-3, which is thought to have an important place in the pathogenesis of Schizophrenia Disease in the literature.
Download Info
×
Paper Access Key
Access Key
Submit
No Access Key (
Request for Download
)
Name
Email
Country
Send Request
Our Certificates
Guidelines
Information For Authors
Information Editorial Board
FAQ
Further Information
Article Processing Charges
Open Access Policy
Terms and Conditions
Privacy Policy
//